Nonvalvular Atrial Fibrillation: Clinical Trials

2 trials for Nonvalvular Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Unknown 1

Follow Nonvalvular Atrial Fibrillation: new trials by email Literature Review of Nonvalvular Atrial Fibrillation trials Research Report on Nonvalvular Atrial Fibrillation

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
Single Antiplatelet Therapy or No Therapy (Control), Non-Antithrombotic Therapy - Nonvalvular Atrial Fibrillation, Aspirin
Phase 4RecruitingOCEAN-SHD Study Group5002025-05-292025-08-15
AntiCoagulants and COGnition
Rivaroxaban 20 MG, Warfarin - Nonvalvular Atrial Fibrillation
Phase 4UnknownUniversity Hospital, Angers482020-02-132022-07-27

Interventions

Rivaroxaban (1)  ·  Warfarin (1)

Sponsors

OCEAN-SHD Study Group (1)  ·  University Hospital, Angers (1)

Countries

France (1)  ·  Japan (1)

Results publications

PMID 42003301

NIH funding

2019 (1)